BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9400521)

  • 1. Non-cardiovascular disease mortality and diabetes mellitus.
    Balkau B; Pyörälä M; Shipley M; Forhan A; Jarrett J; Eschwège E; Pyörälä K
    Lancet; 1997 Dec; 350(9092):1680. PubMed ID: 9400521
    [No Abstract]   [Full Text] [Related]  

  • 2. A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland.
    Barnett KN; Ogston SA; McMurdo ME; Morris AD; Evans JM
    Diabet Med; 2010 Oct; 27(10):1124-9. PubMed ID: 20854379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality in type 2 diabetes.
    Reunanen A
    Ann Clin Res; 1983; 15 Suppl 37():26-8. PubMed ID: 6679186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic differences in mortality among diabetic people in Finland.
    Forssas E; Arffman M; Koskinen S; Reunanen A; Keskimäki I
    Scand J Public Health; 2010 Nov; 38(7):691-8. PubMed ID: 20651001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of cardiovascular mortality in type-2 diabetes by aggressive and early intervention strategies.
    Schernthaner G
    Wien Klin Wochenschr; 1999 Jan; 111(2):43-5. PubMed ID: 10081120
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased orosomucoid in urine is an independent predictor of cardiovascular and all-cause mortality in patients with type 2 diabetes at 10 years of follow-up.
    Svendstrup M; Christiansen MS; Magid E; Hommel E; Feldt-Rasmussen B
    J Diabetes Complications; 2013; 27(6):570-5. PubMed ID: 23932410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical hypothyroidism is associated with reduced all-cause mortality in patients with type 2 diabetes.
    Sathyapalan T; Manuchehri AM; Rigby AS; Atkin SL
    Diabetes Care; 2010 Mar; 33(3):e37. PubMed ID: 20190285
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in all-cause and cardiovascular disease mortality in three different Finnish population cohorts with and without diabetes.
    Barengo NC; Antikainen R; Peltonen M; Tuomilehto J
    Int J Cardiol; 2013 Oct; 168(5):4734-8. PubMed ID: 23962774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Certification of deaths from diabetes mellitus and obesity in England: trends into the twenty-first century.
    Duncan ME; Goldacre MJ
    J Public Health (Oxf); 2013 Jun; 35(2):293-7. PubMed ID: 22961468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal impairment and all-cause mortality in cardiovascular disease: effect modification by type 2 diabetes mellitus.
    Selvarajah S; Uiterwaal CS; Haniff J; van der Graaf Y; Visseren FL; Bots ML;
    Eur J Clin Invest; 2013 Feb; 43(2):198-207. PubMed ID: 23301500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is an intensive glycaemic control beneficial in diabetes type 2?].
    Martin S
    Dtsch Med Wochenschr; 2011 Sep; 136(39):1940. PubMed ID: 21948602
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes and cardiovascular risk equivalency: do age at diagnosis and disease duration affect risk stratification?: comment on "impact of diabetes on cardiovascular disease risk and all-cause mortality in older men".
    Idris I
    Arch Intern Med; 2011 Mar; 171(5):410-1. PubMed ID: 21403037
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-insulin-dependent diabetes and 11-year mortality in Asian Indian and Melanesian Fijians.
    Collins VR; Dowse GK; Ram P; Cabealawa S; Zimmet PZ
    Diabet Med; 1996 Feb; 13(2):125-32. PubMed ID: 8641116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socio-economic predictors of mortality among diabetic people.
    Forssas E; Manderbacka K; Arffman M; Keskimäki I
    Eur J Public Health; 2012 Jun; 22(3):305-10. PubMed ID: 21498561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mortality from cardiovascular diseases in patients with type 2 diabetes].
    Janeczko D; Kopczyński J; Lewandowski Z; Janeczko-Sosnowska E; Tuszyńska A
    Przegl Lek; 2000; 57 Suppl 4():3-7. PubMed ID: 11293227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus.
    Brownrigg JR; de Lusignan S; McGovern A; Hughes C; Thompson MM; Ray KK; Hinchliffe RJ
    Heart; 2014 Dec; 100(23):1837-43. PubMed ID: 25095826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and premature death.
    Sposito AC; Serrano C
    Rev Assoc Med Bras (1992); 2019 Jan; 65(1):1-2. PubMed ID: 30758412
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes.
    Forsblom C; Thomas MC; Moran J; Saraheimo M; Thorn L; Wadén J; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
    J Intern Med; 2011 Oct; 270(4):346-55. PubMed ID: 21615808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk factors as predictors of mortality in type II diabetic patients.
    Mudríková T; Gmitrov J; Tkác I; Gonsorcík J; Szakács M
    Wien Klin Wochenschr; 1999 Jan; 111(2):66-9. PubMed ID: 10081124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.